MedPath

AJOVY

AJOVY

Approved
DIN Number

02497859

Drug Class

Human

Market Date

Aug 4, 2020

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02497859
AIG Number0162154001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
N02CD03 FREMANEZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification28:32.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

FREMANEZUMABActive
Strength: 225 MG / 1.5 ML
Monograph: FREMANEZUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.